Brand Name CLOPZETA-75
Composition Clopidogrel 75mg
Formulation & Packing Tablets | 10×10 Alu-Alu
Therapeutic Class Antiplatelet Agent
Franchise Nett Rate ₹138.00 + GST
Maximum Retail Price (MRP) ₹610.00

Description

CLOPZETA-75 contains 75mg of Clopidogrel  and belongs to the antiplatelet group of medicines. This tablet is used to help prevent harmful blood clots in patients with certain heart and blood-vessel conditions, as prescribed by a doctor.  Clopidogrel works by preventing platelets from sticking together and forming clots. This helps to reduce the risk of problems that are caused by unwanted blood clot formation. 

For pharmaceutical distributors, wholesalers, and PCD franchise partners, CLOPZETA-75 can be included in a Cardiac Diabetic PCD Pharma Franchise portfolio as part of a broader cardiovascular product range. It can be a suitable addition for partners who are looking to expand their portfolio with products used in cardiovascular care. 

How Does CLOPZETA-75 Work?

CLOPZETA-75 contains Clopidogrel, an antiplatelet medicine that helps to prevent harmful blood clots. After taking the medicine, clopidogrel works by blocking a specific receptor on platelets called P2Y12. This makes platelets less likely to stick together and form blood clots. 

By reducing platelet clumping, CLOPZETA-75 helps to lower the risk of certain clot-related heart and blood-vessel problems in patients for whom antiplatelet treatment has been prescribed. 

Dosage & Administration

CLOPZETA-75 should be taken only as prescribed by a doctor. The dose may depend on the patient’s condition and the reason for treatment.

  • In many cases, Clopidogrel 75 mg is taken once daily as maintenance treatment.
  • In some heart-related conditions, the doctor may prescribe a higher first dose (loading dose) before continuing with 75 mg once daily.
  • Take the tablet exactly as directed by your doctor.
  • Do not stop taking CLOPZETA-75 on your own, especially after a heart-related event or coronary procedure, unless your doctor advises you to do so.

PCD Pharma Franchise for Clopidogrel Tablets– Arrowin Pharmaceuticals

Arrowin Pharmaceuticals offers PCD franchise opportunities for Clopidogrel  Tablets under the Medace Cardiac Diabetic portfolio. It is an antiplatelet medicine used to help prevent harmful blood clots in certain cardiovascular conditions, as prescribed by a doctor.

For pharmaceutical distributors, wholesalers, medical representatives, and PCD franchise partners, Clopidogrel Tablets can be added to a broader cardiac and cardiovascular product portfolio. It can complement products covering areas such as hypertension, lipid management, and other cardiac-care requirements.

Key Benefits of CLOPZETA-75 Tablet

  • Helps prevent platelets from sticking together and forming harmful blood clots.
  • Helps reduce the risk of certain heart and blood-vessel problems when prescribed by a doctor.
  • May be used in patients with acute coronary syndrome.
  • May be prescribed after certain heart attacks or ischemic strokes.
  • Can be used in appropriate patients with peripheral arterial disease.
  • Available as a convenient 75 mg tablet.
  • Can be added to a cardiovascular and antiplatelet product portfolio for PCD Pharma Franchise partners.